Delivery Order SPE2DB20D7059-SPE2DB24FPXK4
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,449,252 units of the pharmaceutical drug Oseltamivir Phosphate 75 mg capsules. The $1,022.92 order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a range of pharmaceutical products and medical supplies to the Department of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,945.24 contract is for the supply of 4,563,370,505 units of Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of January 22, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has provided a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,087.36, is for the procurement of 4,567,218,221 units of Oseltamivir Phosphate 75 mg Capsules. The contract has a period of performance through February 11, 2025 and was awarded on February 10, 2025. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,923,335 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The fixed-price delivery order contract, valued at $1,877.00, has a performance period through January 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,554.79 firm fixed-price delivery order contract is for the supply of 4,567,282,823 units of 30 mg Oseltamivir Phosphate capsules. The contract has a ceiling value of $3,554.79 and runs through February 18, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,154.76, is for the delivery of 4,567,269 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. This is a firm-fixed-price delivery order contract with a completion date of February 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the supply of 4,565,901,325 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a firm fixed price of $1,272.60 and a completion date of September 24, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,307,107 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $5,284.09 firm-fixed-price contract has a completion date of November 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,378.24, is for the delivery of 4,567,037,738 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The contract is a firm fixed-price Delivery Order with a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a $1,541.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Oseltamivir Phosphate 75mg capsules. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole awardee. This IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...